Embolotherapy Market Research Report by Product (Embolic Agents and Support Devices), by Disease Indication (Cancer, Gastrointestinal Disorders, Neurological Diseases, Peripheral Vascular Disease, and Urological & Nephrological Disorders), by Procedure, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Embolotherapy Market is expected to grow from USD 3,440.33 Million in 2020 to USD 5,026.79 Million by the end of 2025.
2. The Global Embolotherapy Market is expected to grow from EUR 3,016.54 Million in 2020 to EUR 4,407.58 Million by the end of 2025.
3. The Global Embolotherapy Market is expected to grow from GBP 2,681.71 Million in 2020 to GBP 3,918.35 Million by the end of 2025.
4. The Global Embolotherapy Market is expected to grow from JPY 367,170.63 Million in 2020 to JPY 536,485.91 Million by the end of 2025.
5. The Global Embolotherapy Market is expected to grow from AUD 4,995.82 Million in 2020 to AUD 7,299.56 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Embolotherapy to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the Embolotherapy Market studied across Embolic Agents and Support Devices. The Embolic Agents further studied across Detachable Balloons, Embolic Coils, Embolic Plug Systems, Liquid Embolic Agents, and Microspheres. The Support Devices further studied across Guidewires and Microcatheters.
Based on Disease Indication, the Embolotherapy Market studied across Cancer, Gastrointestinal Disorders, Neurological Diseases, Peripheral Vascular Disease, and Urological & Nephrological Disorders.
Based on Procedure, the Embolotherapy Market studied across Transarterial Chemoembolization, Transcatheter Arterial Embolization, and Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy.
Based on End User, the Embolotherapy Market studied across Ambulatory Surgery Centers and Hospitals and Clinics.
Based on Geography, the Embolotherapy Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Embolotherapy Market including Abbott Laboratories, Acandis GmbH, Balt Extrusion, Boston Scientific Corporation, BTG plc, Cook Medical Incorporated, Johnson & Johnson, Kaneka Corporation, Medtronic plc, Meril Life Sciences Pvt., Ltd., Merit Medical Systems Inc, Penumbra, Inc., Sirtex Medical Limited, Stryker Corporation, and Terumo Corporation.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Embolotherapy Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Embolotherapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Embolotherapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Embolotherapy Market?
4. What is the competitive strategic window for opportunities in the Global Embolotherapy Market?
5. What are the technology trends and regulatory frameworks in the Global Embolotherapy Market?
6. What are the modes and strategic moves considered suitable for entering the Global Embolotherapy Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Embolotherapy Market is expected to grow from USD 3,440.33 Million in 2020 to USD 5,026.79 Million by the end of 2025.
2. The Global Embolotherapy Market is expected to grow from EUR 3,016.54 Million in 2020 to EUR 4,407.58 Million by the end of 2025.
3. The Global Embolotherapy Market is expected to grow from GBP 2,681.71 Million in 2020 to GBP 3,918.35 Million by the end of 2025.
4. The Global Embolotherapy Market is expected to grow from JPY 367,170.63 Million in 2020 to JPY 536,485.91 Million by the end of 2025.
5. The Global Embolotherapy Market is expected to grow from AUD 4,995.82 Million in 2020 to AUD 7,299.56 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Embolotherapy to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the Embolotherapy Market studied across Embolic Agents and Support Devices. The Embolic Agents further studied across Detachable Balloons, Embolic Coils, Embolic Plug Systems, Liquid Embolic Agents, and Microspheres. The Support Devices further studied across Guidewires and Microcatheters.
Based on Disease Indication, the Embolotherapy Market studied across Cancer, Gastrointestinal Disorders, Neurological Diseases, Peripheral Vascular Disease, and Urological & Nephrological Disorders.
Based on Procedure, the Embolotherapy Market studied across Transarterial Chemoembolization, Transcatheter Arterial Embolization, and Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy.
Based on End User, the Embolotherapy Market studied across Ambulatory Surgery Centers and Hospitals and Clinics.
Based on Geography, the Embolotherapy Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Embolotherapy Market including Abbott Laboratories, Acandis GmbH, Balt Extrusion, Boston Scientific Corporation, BTG plc, Cook Medical Incorporated, Johnson & Johnson, Kaneka Corporation, Medtronic plc, Meril Life Sciences Pvt., Ltd., Merit Medical Systems Inc, Penumbra, Inc., Sirtex Medical Limited, Stryker Corporation, and Terumo Corporation.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Embolotherapy Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Embolotherapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Embolotherapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Embolotherapy Market?
4. What is the competitive strategic window for opportunities in the Global Embolotherapy Market?
5. What are the technology trends and regulatory frameworks in the Global Embolotherapy Market?
6. What are the modes and strategic moves considered suitable for entering the Global Embolotherapy Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Procedure Outlook
3.5. End User Outlook
3.6. Disease Indication Outlook
3.7. Geography Outlook
3.8. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing target patient population
5.1.1.2. Rising patient preference for minimally invasive procedures
5.1.1.3. Investment & funding by government and private organizations
5.1.1.4. Technology advancements in embolotherapy devices
5.1.1.5. Favorable reimbursement scenario for minimally invasive surgeries
5.1.2. Restraints
5.1.2.1. Lack of sufficient evidence & unfavorable regulatory scenario
5.1.2.2. Strong market positioning of alternative therapies
5.1.3. Opportunities
5.1.3.1. Growth opportunities in emerging markets
5.1.3.2. Expanding applications of embolization devices
5.1.4. Challenges
5.1.4.1. Lack of skilled surgeons
5.1.4.2. High cost and resulting difficulties in accessing embolization in developing countries
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL EMBOLOTHERAPY MARKET, BY PRODUCT
6.1. Introduction
6.2. Embolic Agents
6.2.1. Detachable Balloons
6.2.2. Embolic Coils
6.2.3. Embolic Plug Systems
6.2.4. Liquid Embolic Agents
6.2.5. Microspheres
6.3. Support Devices
6.3.1. Guidewires
6.3.2. Microcatheters
7. GLOBAL EMBOLOTHERAPY MARKET, BY DISEASE INDICATION
7.1. Introduction
7.2. Cancer
7.3. Gastrointestinal Disorders
7.4. Neurological Diseases
7.5. Peripheral Vascular Disease
7.6. Urological & Nephrological Disorders
8. GLOBAL EMBOLOTHERAPY MARKET, BY PROCEDURE
8.1. Introduction
8.2. Transarterial Chemoembolization
8.3. Transcatheter Arterial Embolization
8.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
9. GLOBAL EMBOLOTHERAPY MARKET, BY END USER
9.1. Introduction
9.2. Ambulatory Surgery Centers
9.3. Hospitals and Clinics
10. AMERICAS EMBOLOTHERAPY MARKET
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. ASIA-PACIFIC EMBOLOTHERAPY MARKET
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand
12. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. COMPETITIVE LANDSCAPE
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitor SWOT Analysis
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion
14. COMPANY USABILITY PROFILES
14.1. Abbott Laboratories
14.2. Acandis GmbH
14.3. Balt Extrusion
14.4. Boston Scientific Corporation
14.5. BTG plc
14.6. Cook Medical Incorporated
14.7. Johnson & Johnson
14.8. Kaneka Corporation
14.9. Medtronic plc
14.10. Meril Life Sciences Pvt., Ltd.
14.11. Merit Medical Systems Inc
14.12. Penumbra, Inc.
14.13. Sirtex Medical Limited
14.14. Stryker Corporation
14.15. Terumo Corporation
15. APPENDIX
15.1. Discussion Guide
15.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Procedure Outlook
3.5. End User Outlook
3.6. Disease Indication Outlook
3.7. Geography Outlook
3.8. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing target patient population
5.1.1.2. Rising patient preference for minimally invasive procedures
5.1.1.3. Investment & funding by government and private organizations
5.1.1.4. Technology advancements in embolotherapy devices
5.1.1.5. Favorable reimbursement scenario for minimally invasive surgeries
5.1.2. Restraints
5.1.2.1. Lack of sufficient evidence & unfavorable regulatory scenario
5.1.2.2. Strong market positioning of alternative therapies
5.1.3. Opportunities
5.1.3.1. Growth opportunities in emerging markets
5.1.3.2. Expanding applications of embolization devices
5.1.4. Challenges
5.1.4.1. Lack of skilled surgeons
5.1.4.2. High cost and resulting difficulties in accessing embolization in developing countries
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL EMBOLOTHERAPY MARKET, BY PRODUCT
6.1. Introduction
6.2. Embolic Agents
6.2.1. Detachable Balloons
6.2.2. Embolic Coils
6.2.3. Embolic Plug Systems
6.2.4. Liquid Embolic Agents
6.2.5. Microspheres
6.3. Support Devices
6.3.1. Guidewires
6.3.2. Microcatheters
7. GLOBAL EMBOLOTHERAPY MARKET, BY DISEASE INDICATION
7.1. Introduction
7.2. Cancer
7.3. Gastrointestinal Disorders
7.4. Neurological Diseases
7.5. Peripheral Vascular Disease
7.6. Urological & Nephrological Disorders
8. GLOBAL EMBOLOTHERAPY MARKET, BY PROCEDURE
8.1. Introduction
8.2. Transarterial Chemoembolization
8.3. Transcatheter Arterial Embolization
8.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
9. GLOBAL EMBOLOTHERAPY MARKET, BY END USER
9.1. Introduction
9.2. Ambulatory Surgery Centers
9.3. Hospitals and Clinics
10. AMERICAS EMBOLOTHERAPY MARKET
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. ASIA-PACIFIC EMBOLOTHERAPY MARKET
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand
12. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. COMPETITIVE LANDSCAPE
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitor SWOT Analysis
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion
14. COMPANY USABILITY PROFILES
14.1. Abbott Laboratories
14.2. Acandis GmbH
14.3. Balt Extrusion
14.4. Boston Scientific Corporation
14.5. BTG plc
14.6. Cook Medical Incorporated
14.7. Johnson & Johnson
14.8. Kaneka Corporation
14.9. Medtronic plc
14.10. Meril Life Sciences Pvt., Ltd.
14.11. Merit Medical Systems Inc
14.12. Penumbra, Inc.
14.13. Sirtex Medical Limited
14.14. Stryker Corporation
14.15. Terumo Corporation
15. APPENDIX
15.1. Discussion Guide
15.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL EMBOLOTHERAPY MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DETACHABLE BALLOONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC COILS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC PLUG SYSTEMS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLIC AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY MICROSPHERES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GUIDEWIRES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY MICROCATHETERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY CANCER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY NEUROLOGICAL DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY UROLOGICAL & NEPHROLOGICAL DISORDERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSCATHETER ARTERIAL EMBOLIZATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSCATHETER ARTERIAL RADIOEMBOLIZATION/SELECTIVE INTERNAL RADIATION THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. CANADA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. CANADA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. CANADA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. CANADA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. MEXICO EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. MEXICO EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. MEXICO EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. MEXICO EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. CHINA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. CHINA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. CHINA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. CHINA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. INDIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. INDIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. INDIA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. INDIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. JAPAN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. JAPAN EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. JAPAN EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. JAPAN EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. THAILAND EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. THAILAND EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. THAILAND EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. THAILAND EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. FRANCE EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. FRANCE EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. FRANCE EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. FRANCE EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. GERMANY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. GERMANY EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. GERMANY EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. GERMANY EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. ITALY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. ITALY EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. ITALY EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. ITALY EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. QATAR EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. QATAR EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. QATAR EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. QATAR EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. SPAIN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. SPAIN EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. SPAIN EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. SPAIN EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 138. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 139. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 140. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 141. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 142. GLOBAL EMBOLOTHERAPY MARKET: SCORES
TABLE 143. GLOBAL EMBOLOTHERAPY MARKET: BUSINESS STRATEGY
TABLE 144. GLOBAL EMBOLOTHERAPY MARKET: PRODUCT SATISFACTION
TABLE 145. GLOBAL EMBOLOTHERAPY MARKET: RANKING
TABLE 146. GLOBAL EMBOLOTHERAPY MARKET: MERGER & ACQUISITION
TABLE 147. GLOBAL EMBOLOTHERAPY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 148. GLOBAL EMBOLOTHERAPY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 149. GLOBAL EMBOLOTHERAPY MARKET: INVESTMENT & FUNDING
TABLE 150. GLOBAL EMBOLOTHERAPY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 151. GLOBAL EMBOLOTHERAPY MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL EMBOLOTHERAPY MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DETACHABLE BALLOONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC COILS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC PLUG SYSTEMS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLIC AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY MICROSPHERES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GUIDEWIRES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY MICROCATHETERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY CANCER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY NEUROLOGICAL DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY UROLOGICAL & NEPHROLOGICAL DISORDERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSCATHETER ARTERIAL EMBOLIZATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSCATHETER ARTERIAL RADIOEMBOLIZATION/SELECTIVE INTERNAL RADIATION THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. CANADA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. CANADA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. CANADA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. CANADA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. MEXICO EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. MEXICO EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. MEXICO EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. MEXICO EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. CHINA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. CHINA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. CHINA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. CHINA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. INDIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. INDIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. INDIA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. INDIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. JAPAN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. JAPAN EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. JAPAN EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. JAPAN EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. THAILAND EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. THAILAND EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. THAILAND EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. THAILAND EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. FRANCE EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. FRANCE EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. FRANCE EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. FRANCE EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. GERMANY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. GERMANY EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. GERMANY EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. GERMANY EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. ITALY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. ITALY EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. ITALY EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. ITALY EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. QATAR EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. QATAR EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. QATAR EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. QATAR EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. SPAIN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. SPAIN EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. SPAIN EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. SPAIN EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 138. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 139. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 140. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 141. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 142. GLOBAL EMBOLOTHERAPY MARKET: SCORES
TABLE 143. GLOBAL EMBOLOTHERAPY MARKET: BUSINESS STRATEGY
TABLE 144. GLOBAL EMBOLOTHERAPY MARKET: PRODUCT SATISFACTION
TABLE 145. GLOBAL EMBOLOTHERAPY MARKET: RANKING
TABLE 146. GLOBAL EMBOLOTHERAPY MARKET: MERGER & ACQUISITION
TABLE 147. GLOBAL EMBOLOTHERAPY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 148. GLOBAL EMBOLOTHERAPY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 149. GLOBAL EMBOLOTHERAPY MARKET: INVESTMENT & FUNDING
TABLE 150. GLOBAL EMBOLOTHERAPY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 151. GLOBAL EMBOLOTHERAPY MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL EMBOLOTHERAPY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL EMBOLOTHERAPY MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL EMBOLOTHERAPY MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 5. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2020 (USD MILLION)
FIGURE 6. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 7. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2020 (USD MILLION)
FIGURE 8. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 9. GLOBAL EMBOLOTHERAPY MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 10. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 11. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 13. GLOBAL EMBOLOTHERAPY MARKET: MARKET DYNAMICS
FIGURE 14. GLOBAL EMBOLOTHERAPY MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 15. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2020 VS 2025 (%)
FIGURE 16. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2020 VS 2025 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2025
FIGURE 18. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DETACHABLE BALLOONS, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC COILS, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC PLUG SYSTEMS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY MICROSPHERES, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GUIDEWIRES, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY MICROCATHETERS, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2020 VS 2025 (%)
FIGURE 28. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2025
FIGURE 30. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY CANCER, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY NEUROLOGICAL DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY UROLOGICAL & NEPHROLOGICAL DISORDERS, 2020 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2020 VS 2025 (%)
FIGURE 36. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2020 VS 2025 (USD MILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2025
FIGURE 38. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSCATHETER ARTERIAL EMBOLIZATION, 2020 VS 2025 (USD MILLION)
FIGURE 40. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSCATHETER ARTERIAL RADIOEMBOLIZATION/SELECTIVE INTERNAL RADIATION THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 41. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2020 VS 2025 (%)
FIGURE 42. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2020 VS 2025 (USD MILLION)
FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025
FIGURE 44. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2020 VS 2025 (USD MILLION)
FIGURE 45. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, 2020 VS 2025 (USD MILLION)
FIGURE 46. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 47. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 49. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. CANADA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. MEXICO EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 55. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 56. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 57. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. CHINA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. INDIA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. JAPAN EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. THAILAND EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 67. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 68. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 69. FRANCE EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. GERMANY EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. ITALY EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. QATAR EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 74. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 75. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 76. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 77. SPAIN EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 78. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 79. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 80. GLOBAL EMBOLOTHERAPY MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 81. GLOBAL EMBOLOTHERAPY MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 82. GLOBAL EMBOLOTHERAPY MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 83. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL EMBOLOTHERAPY MARKET, BY TYPE
FIGURE 1. GLOBAL EMBOLOTHERAPY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL EMBOLOTHERAPY MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL EMBOLOTHERAPY MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 5. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2020 (USD MILLION)
FIGURE 6. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 7. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2020 (USD MILLION)
FIGURE 8. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 9. GLOBAL EMBOLOTHERAPY MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 10. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 11. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 13. GLOBAL EMBOLOTHERAPY MARKET: MARKET DYNAMICS
FIGURE 14. GLOBAL EMBOLOTHERAPY MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 15. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2020 VS 2025 (%)
FIGURE 16. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2020 VS 2025 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2025
FIGURE 18. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DETACHABLE BALLOONS, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC COILS, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC PLUG SYSTEMS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY MICROSPHERES, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GUIDEWIRES, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY MICROCATHETERS, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2020 VS 2025 (%)
FIGURE 28. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2025
FIGURE 30. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY CANCER, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY NEUROLOGICAL DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY UROLOGICAL & NEPHROLOGICAL DISORDERS, 2020 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2020 VS 2025 (%)
FIGURE 36. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2020 VS 2025 (USD MILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2025
FIGURE 38. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSCATHETER ARTERIAL EMBOLIZATION, 2020 VS 2025 (USD MILLION)
FIGURE 40. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSCATHETER ARTERIAL RADIOEMBOLIZATION/SELECTIVE INTERNAL RADIATION THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 41. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2020 VS 2025 (%)
FIGURE 42. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2020 VS 2025 (USD MILLION)
FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025
FIGURE 44. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2020 VS 2025 (USD MILLION)
FIGURE 45. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, 2020 VS 2025 (USD MILLION)
FIGURE 46. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 47. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 49. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. CANADA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. MEXICO EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 55. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 56. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 57. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. CHINA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. INDIA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. JAPAN EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. THAILAND EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 67. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 68. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 69. FRANCE EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. GERMANY EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. ITALY EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. QATAR EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 74. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 75. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 76. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 77. SPAIN EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 78. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 79. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 80. GLOBAL EMBOLOTHERAPY MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 81. GLOBAL EMBOLOTHERAPY MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 82. GLOBAL EMBOLOTHERAPY MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 83. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL EMBOLOTHERAPY MARKET, BY TYPE
